FREE PROSTATE-SPECIFIC ANTIGEN DECREASED

FREE PROSTATE-SPECIFIC ANTIGEN DECREASED was reported 19 times

FREE PROSTATE-SPECIFIC ANTIGEN DECREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Radioligand Therapeutic Agent [EPC] 1 0.0001
1 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
2 Androgen Receptor Inhibitor [EPC] 1 0.0000
3 Interleukin-23 Antagonist [EPC] 1 0.0000
4 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
5 Thalidomide Analog [EPC] 2 0.0000
6 Platelet Aggregation Inhibitor [EPC] 2 0.0000
7 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
8 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
9 Proton Pump Inhibitor [EPC] 1 0.0000
10 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000
11 Corticosteroid [EPC] 1 0.0000